ALPMF·006985383·US·equity·Healthcare - Drug Manufacturers - General
Common Stock - Foreign
ALPMF (Astellas Pharma, Inc.) is held by 1 institutional investors as of Q4 2025. Largest holders: Pacer Advisors, Inc. ($26.1M).
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer